pharmaceuticals | Science and Enterprise

New post on Science and Enterprise: Editorial Posts Resume Tomorrow https://t.co/ZTVMsYlwg8 #Science #Business
about 6 hours ago
As mobile phones, smart watches, and tablets play an increasingly key role in our daily lives, a new report shows m… https://t.co/HNOl3qa4oI
about 2 days ago
New post on Science and Enterprise: Infographic – Mobile Industry’s Economic Role https://t.co/aMBZtn0gkM #Science #Business
about 2 days ago
FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug https://t.co/srCucGLuB5
about 3 days ago
A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million i… https://t.co/gn4NSNTmBR
about 3 days ago

Companies Call for Genome Editing Regulations

By Alan, on August 28th, 2019%

A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine. . . . → Read More: Companies Call for Genome Editing Regulations

Patch Designed for Vaccines, Cancer Treatments

By Alan, on August 26th, 2019%

An engineering team designed a small skin patch with tiny needles that in lab mice quickly delivers vaccines and possibly treatments for melanoma. . . . → Read More: Patch Designed for Vaccines, Cancer Treatments

Crispr Deployed for Programmable Smart Hydrogels

By Alan, on August 23rd, 2019%

Bio-engineers developed a process using the gene editing technique Crispr to design gel materials with properties added for drug delivery, diagnostics, and electronic circuits. . . . → Read More: Crispr Deployed for Programmable Smart Hydrogels

Small Biz Grant Funds Pre-Term Gut Microbe Therapy

By Alan, on August 21st, 2019%

National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants. . . . → Read More: Small Biz Grant Funds Pre-Term Gut Microbe Therapy

Carb-X Funds Drug-Resistant Bacterial Vaccine

By Alan, on August 20th, 2019%

A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine

FDA Okays Celiac Disease Engineered Microbe Trial

By Alan, on August 19th, 2019%

A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial

Aging Therapy Network Adds $100M to Venture Round

By Alan, on August 19th, 2019%

An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round. . . . → Read More: Aging Therapy Network Adds $100M to Venture Round

Controlled Brain Tumor Gene Therapy Shown Safe

By Alan, on August 15th, 2019%

A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer. . . . → Read More: Controlled Brain Tumor Gene Therapy Shown Safe

Trial Shows Two Drugs Can Treat Ebola Virus

By Alan, on August 13th, 2019%

A clinical trial in the Congo shows two different therapies made with synthetic antibodies are better able to treat Ebola infections than two other drugs tested. . . . → Read More: Trial Shows Two Drugs Can Treat Ebola Virus

Engineered Bacteria Hydrogels Designed for Gut Repair

By Alan, on August 12th, 2019%

Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces. . . . → Read More: Engineered Bacteria Hydrogels Designed for Gut Repair

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise